Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2dux | ZST | Aldose reductase | 1.1.1.21 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2dux | ZST | Aldose reductase | 1.1.1.21 | 1.000 | |
2duz | ZST | Aldose reductase | 1.1.1.21 | 0.806 | |
2i17 | LDT | Aldose reductase | 1.1.1.21 | 0.768 | |
3ght | LDT | Aldose reductase | 1.1.1.21 | 0.747 | |
3ld5 | LDT | Aldose reductase | 1.1.1.21 | 0.747 | |
2pdg | 47D | Aldose reductase | 1.1.1.21 | 0.734 | |
1z3n | 3NA | Aldose reductase | 1.1.1.21 | 0.719 | |
3ghs | LDT | Aldose reductase | 1.1.1.21 | 0.716 | |
2hvo | ZST | Aldose reductase | 1.1.1.21 | 0.707 | |
3g5e | Q74 | Aldose reductase | 1.1.1.21 | 0.700 | |
3ghr | LDT | Aldose reductase | 1.1.1.21 | 0.700 | |
3ghu | LDT | Aldose reductase | 1.1.1.21 | 0.699 | |
3m4h | 388 | Aldose reductase | 1.1.1.21 | 0.699 | |
1t40 | ID5 | Aldose reductase | 1.1.1.21 | 0.698 | |
4yu1 | 53N | Aldose reductase | 1.1.1.21 | 0.695 | |
2i16 | LDT | Aldose reductase | 1.1.1.21 | 0.685 | |
3lbo | LDT | Aldose reductase | 1.1.1.21 | 0.685 | |
2qxw | LDT | Aldose reductase | 1.1.1.21 | 0.677 | |
3lql | LDT | Aldose reductase | 1.1.1.21 | 0.671 | |
3mb9 | ZST | Aldose reductase | 1.1.1.21 | 0.671 | |
1pwl | BFI | Aldose reductase | 1.1.1.21 | 0.669 | |
4gca | 2X9 | Aldose reductase | 1.1.1.21 | 0.657 | |
3len | ZST | Aldose reductase | 1.1.1.21 | 0.651 | |
1t41 | ID5 | Aldose reductase | 1.1.1.21 | 0.649 | |
1us0 | LDT | Aldose reductase | 1.1.1.21 | 0.648 | |
2pdn | 47D | Aldose reductase | 1.1.1.21 | 0.647 | |
2pdp | 393 | Aldose reductase | 1.1.1.21 | 0.647 | |
2pzn | 393 | Aldose reductase | 1.1.1.21 | 0.647 | |
2pdx | ZST | Aldose reductase | 1.1.1.21 | 0.642 | |
2iki | 388 | Aldose reductase | 1.1.1.21 | 0.641 | |
2pdc | 393 | Aldose reductase | 1.1.1.21 | 0.625 | |
3t42 | 3T4 | Aldose reductase | 1.1.1.21 | 0.624 | |
2pd5 | ZST | Aldose reductase | 1.1.1.21 | 0.621 | |
2pdh | 47D | Aldose reductase | 1.1.1.21 | 0.620 | |
2pdu | 393 | Aldose reductase | 1.1.1.21 | 0.619 | |
2pdb | ZST | Aldose reductase | 1.1.1.21 | 0.618 | |
3m64 | 393 | Aldose reductase | 1.1.1.21 | 0.618 | |
3m0i | ZST | Aldose reductase | 1.1.1.21 | 0.610 | |
2pdf | ZST | Aldose reductase | 1.1.1.21 | 0.608 | |
2dv0 | ZST | Aldose reductase | 1.1.1.21 | 0.606 | |
3mc5 | 393 | Aldose reductase | 1.1.1.21 | 0.603 | |
1z89 | 62P | Aldose reductase | 1.1.1.21 | 0.600 | |
2fz8 | ZST | Aldose reductase | 1.1.1.21 | 0.597 | |
2pdq | 47D | Aldose reductase | 1.1.1.21 | 0.596 | |
2ikj | 393 | Aldose reductase | 1.1.1.21 | 0.595 | |
2hv5 | ZST | Aldose reductase | 1.1.1.21 | 0.593 | |
1frb | ZST | Aldose reductase-related protein 2 | / | 0.591 | |
2ikh | LIT | Aldose reductase | 1.1.1.21 | 0.589 | |
2pdj | 393 | Aldose reductase | 1.1.1.21 | 0.583 | |
2fz9 | ZST | Aldose reductase | 1.1.1.21 | 0.581 | |
1ah3 | TOL | Aldose reductase | 1.1.1.21 | 0.570 | |
1el3 | I84 | Aldose reductase | 1.1.1.21 | 0.569 | |
3lz5 | LDT | Aldose reductase | 1.1.1.21 | 0.565 | |
1iei | ZES | Aldose reductase | 1.1.1.21 | 0.561 | |
2pdl | TOL | Aldose reductase | 1.1.1.21 | 0.554 | |
2fzd | TOL | Aldose reductase | 1.1.1.21 | 0.538 | |
2fzb | TOL | Aldose reductase | 1.1.1.21 | 0.510 | |
5liu | 388 | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.509 | |
2jf0 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.492 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.491 | |
4kn1 | 04J | Folate receptor beta | / | 0.491 | |
2agt | FID | Aldose reductase | 1.1.1.21 | 0.490 | |
2xuj | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.489 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.489 | |
4kmz | FOL | Folate receptor beta | / | 0.488 | |
1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.486 | |
3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.483 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.483 | |
3mjr | AC2 | Deoxycytidine kinase | 2.7.1.74 | 0.481 | |
2vt4 | P32 | Beta-1 adrenergic receptor | / | 0.480 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.479 | |
2xuf | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.478 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.478 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.478 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.477 | |
4kn2 | LYA | Folate receptor beta | / | 0.477 | |
4wev | SUZ | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.477 | |
4eil | FOL | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.476 | |
2cbq | TH2 | Neocarzinostatin | / | 0.474 | |
8cat | NDP | Catalase | 1.11.1.6 | 0.474 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.473 | |
3nub | UD0 | UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase | 2.6.1.98 | 0.473 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.472 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.472 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.471 | |
1gpn | HUB | Acetylcholinesterase | 3.1.1.7 | 0.470 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.470 | |
4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.470 | |
2cek | N8T | Acetylcholinesterase | 3.1.1.7 | 0.469 | |
4phl | PIL | Phosphodiesterase | / | 0.469 | |
2iqd | LPA | Aldose reductase | 1.1.1.21 | 0.468 | |
2v0m | KLN | Cytochrome P450 3A4 | / | 0.468 | |
3hxe | BD8 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.467 | |
3g1r | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.466 | |
3ox2 | 79X | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.466 | |
3szf | DCQ | Sulfide-quinone reductase | / | 0.466 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.466 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.465 | |
3u2c | SUZ | Aldose reductase | 1.1.1.21 | 0.465 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.465 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.465 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.464 | |
1ro6 | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.464 | |
2pd9 | FID | Aldose reductase | 1.1.1.21 | 0.464 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.464 | |
3keg | MRE | FMN-dependent NADH-azoreductase 1 | / | 0.464 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.464 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.464 | |
1efy | BZC | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.463 | |
1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.463 | |
1xf0 | ASD | Aldo-keto reductase family 1 member C3 | / | 0.463 | |
4fam | 0SZ | Aldo-keto reductase family 1 member C3 | / | 0.463 | |
4li6 | 1XO | Tankyrase-1 | 2.4.2.30 | 0.463 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.462 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.462 | |
2f2k | TGG | Aldose reductase | 1.1.1.21 | 0.462 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.462 | |
3aiv | HBO | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase, chloroplastic | 3.2.1.182 | 0.462 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
3t0k | DCQ | Sulfide-quinone reductase | / | 0.462 | |
1p91 | SAM | 23S rRNA (guanine(745)-N(1))-methyltransferase | / | 0.461 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.461 | |
4pab | THG | Dimethylglycine dehydrogenase, mitochondrial | 1.5.8.4 | 0.461 | |
1s1r | NAP | Aldo-keto reductase family 1 member C3 | / | 0.460 | |
2bjs | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
1e66 | HUX | Acetylcholinesterase | 3.1.1.7 | 0.459 | |
1gt5 | BZQ | Odorant-binding protein | / | 0.459 | |
3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
3n0h | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
1ah0 | SBI | Aldose reductase | 1.1.1.21 | 0.458 | |
1ihi | IU5 | Aldo-keto reductase family 1 member C2 | / | 0.458 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
3dyq | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.458 | |
3g4l | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
4ara | C56 | Acetylcholinesterase | 3.1.1.7 | 0.458 | |
4dbu | BT9 | Aldo-keto reductase family 1 member C3 | / | 0.458 | |
4u16 | 3C0 | Muscarinic acetylcholine receptor M3 | / | 0.458 | |
2c1z | U2F | Anthocyanidin 3-O-glucosyltransferase 2 | 2.4.1.115 | 0.457 | |
2is7 | 2CL | Aldose reductase | 1.1.1.21 | 0.457 | |
2xi4 | AFT | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.457 | |
4kn0 | MTX | Folate receptor beta | / | 0.457 | |
4m0f | 1YK | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
3uzz | TES | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.456 | |
4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.456 | |
1pj6 | FOL | Dimethylglycine oxidase | 1.5.3.10 | 0.455 | |
1qv0 | CZH | Obelin | / | 0.455 | |
1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.455 | |
2xje | U5P | Cytosolic purine 5'-nucleotidase | 3.1.3.5 | 0.455 | |
3hxd | BD7 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.455 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.455 | |
3v35 | NTI | Aldose reductase | 1.1.1.21 | 0.455 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.455 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.455 | |
4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.455 | |
1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
1zua | TOL | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.454 | |
2xuh | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.454 | |
3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.454 | |
3zj6 | VM2 | Raucaffricine-O-beta-D-glucosidase | 3.2.1.125 | 0.454 | |
4lrh | FOL | Folate receptor alpha | / | 0.454 | |
4x3u | SVR | Chromobox protein homolog 7 | / | 0.454 | |
1s36 | CEI | Obelin | / | 0.453 | |
2fm0 | M98 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
3uzx | AOM | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.453 | |
3zv7 | NHG | Acetylcholinesterase | 3.1.1.7 | 0.453 | |
4e0u | 0MV | Cyclic dipeptide N-prenyltransferase | / | 0.453 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
4k4e | K4E | Tankyrase-1 | 2.4.2.30 | 0.453 | |
2psj | CEI | Renilla-luciferin 2-monooxygenase | 1.13.12.5 | 0.452 | |
3r58 | NPS | Aldo-keto reductase family 1 member C3 | / | 0.452 | |
4i9z | 5BA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.452 | |
4mm7 | 29J | Na(+):neurotransmitter symporter (Snf family) | / | 0.452 | |
4mrx | CZH | Obelin | / | 0.452 | |
1tfz | 869 | 4-hydroxyphenylpyruvate dioxygenase | 1.13.11.27 | 0.451 | |
1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.451 | |
2c1z | KMP | Anthocyanidin 3-O-glucosyltransferase 2 | 2.4.1.115 | 0.451 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
4bjc | RPB | Tankyrase-2 | 2.4.2.30 | 0.451 | |
1uhj | CZB | Aequorin-2 | / | 0.450 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.450 | |
3r8h | ZOM | Aldo-keto reductase family 1 member C3 | / | 0.450 | |
4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.450 | |
4bjb | P34 | Tankyrase-2 | 2.4.2.30 | 0.450 | |
4dz5 | NAP | Aldo-keto reductase family 1 member C3 | / | 0.450 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.449 | |
1u65 | CP0 | Acetylcholinesterase | 3.1.1.7 | 0.449 | |
2ea4 | F79 | Methionine aminopeptidase 2 | / | 0.449 | |
2nmt | MIM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.449 | |
2pdy | FID | Aldose reductase | 1.1.1.21 | 0.449 | |
3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
3jq8 | DX3 | Pteridine reductase, putative | / | 0.449 | |
4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.449 | |
4ga8 | SBI | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.449 | |
1ah4 | NAP | Aldose reductase | 1.1.1.21 | 0.448 | |
1hqt | NAP | Alcohol dehydrogenase [NADP(+)] | 1.1.1.2 | 0.448 | |
1pwm | FID | Aldose reductase | 1.1.1.21 | 0.448 | |
1tkc | M6T | Transketolase 1 | 2.2.1.1 | 0.448 | |
1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.448 | |
1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.448 | |
2aot | 2PM | Histamine N-methyltransferase | 2.1.1.8 | 0.448 | |
2inz | OHP | Aldose reductase | 1.1.1.21 | 0.448 | |
2qry | TPS | Thiamine-binding periplasmic protein | / | 0.448 | |
3b82 | NAD | Exotoxin A | 2.4.2.36 | 0.448 | |
3fap | ARD | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.448 | |
3fap | ARD | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.448 | |
3gx9 | TXD | Morphinone reductase | / | 0.448 | |
3hgg | CHD | CmeR | / | 0.448 | |
3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.448 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
4ey6 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.448 | |
4gts | 7TP | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.448 | |
1eko | I84 | Aldose reductase | 1.1.1.21 | 0.447 | |
1ro9 | 8BR | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.447 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.447 | |
2fzj | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
2xui | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
3dop | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.447 | |
3fvu | IAC | Kynurenine--oxoglutarate transaminase 1 | 2.6.1.7 | 0.447 | |
3u57 | DH8 | Raucaffricine-O-beta-D-glucosidase | 3.2.1.125 | 0.447 | |
3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.447 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.447 | |
4fl0 | PLP | Aminotransferase ALD1, chloroplastic | 2.6.1 | 0.447 | |
4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
5std | UNN | Scytalone dehydratase | 4.2.1.94 | 0.447 | |
5cxv | 0HK | Muscarinic acetylcholine receptor M1 | / | 0.447 | |
1kyx | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.446 | |
1pj7 | FFO | Dimethylglycine oxidase | 1.5.3.10 | 0.446 | |
1v08 | NTZ | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase 1, chloroplastic | 3.2.1.182 | 0.446 | |
2d06 | EST | Sulfotransferase 1A1 | 2.8.2.1 | 0.446 | |
2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.446 | |
3h7r | NAP | Aldo-keto reductase family 4 member C8 | / | 0.446 | |
3q9b | B3N | Acetylpolyamine amidohydrolase | / | 0.446 | |
3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.446 | |
4d2d | ALA_ALA_ALA | Di-or tripeptide:H+ symporter | / | 0.446 | |
4gvs | F4M | Methenyltetrahydromethanopterin cyclohydrolase | 3.5.4.27 | 0.446 | |
4kxj | P34 | Nucleoprotein | / | 0.446 | |
4u95 | MIY | Multidrug efflux pump subunit AcrB | / | 0.446 | |
1az2 | NAP | Aldose reductase | 1.1.1.21 | 0.445 | |
1kyv | RBF | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.445 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.445 | |
2gyu | HI6 | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
2qjp | ANJ | Cytochrome b | / | 0.445 | |
3aos | JH2 | Hemolymph juvenile hormone binding protein | / | 0.445 | |
3bv7 | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.445 | |
3o73 | O73 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.445 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
3r43 | ID8 | Aldo-keto reductase family 1 member C3 | / | 0.445 | |
3x04 | GNP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.445 | |
4q7f | 3D1 | Uncharacterized protein | / | 0.445 | |
5c1g | GDU | Histo-blood group ABO system transferase | / | 0.445 | |
1dgb | NDP | Catalase | 1.11.1.6 | 0.444 | |
1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | 1.2.4.1 | 0.444 | |
1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | 1.2.4.1 | 0.444 | |
1u08 | PLP | Methionine aminotransferase | / | 0.444 | |
1ut6 | A8N | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
1w6j | R71 | Lanosterol synthase | 5.4.99.7 | 0.444 | |
2ckm | AA7 | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
2gyw | OBI | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
2pdi | ZST | Aldose reductase | 1.1.1.21 | 0.444 | |
2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.444 | |
4b7z | Q4Q | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
2poq | ISD | Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase | 1.3.1.20 | 0.443 | |
2qim | ZEA | Class 10 plant pathogenesis-related protein | / | 0.443 | |
3caq | NDP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.443 | |
4kak | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
4kfj | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1a26 | CNA | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.442 | |
1i5r | HYC | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.442 | |
1ndy | FR3 | Adenosine deaminase | 3.5.4.4 | 0.442 | |
1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.442 | |
2gms | P0P | Putative pyridoxamine 5-phosphate-dependent dehydrase | / | 0.442 | |
2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3aiq | HBO | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase 1b, chloroplastic | 3.2.1.182 | 0.442 | |
3cas | ASD | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.442 | |
3o57 | ZG2 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.442 | |
3ug8 | IMN | Aldo-keto reductase family 1 member C3 | / | 0.442 | |
3v36 | NAP | Aldose reductase | 1.1.1.21 | 0.442 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
2ycz | I32 | Beta-1 adrenergic receptor | / | 0.442 | |
1dtp | APU | Diphtheria toxin | / | 0.441 | |
1gg5 | E09 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
1kmy | BPY | Biphenyl-2,3-diol 1,2-dioxygenase | 1.13.11.39 | 0.441 | |
1w4l | GL8 | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
2b04 | CHO | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.441 | |
2j9f | THV | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial | 1.2.4.4 | 0.441 | |
2j9f | THV | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 1.2.4.4 | 0.441 | |
2y1w | 849 | Histone-arginine methyltransferase CARM1 | / | 0.441 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
3k45 | 51P | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
3ocw | 3AM | Lipoprotein E | / | 0.441 | |
3r8g | IZP | Aldo-keto reductase family 1 member C3 | / | 0.441 | |
3uwe | VJJ | Aldo-keto reductase family 1 member C3 | / | 0.441 | |
3wd2 | A1L | Chitinase B | 3.2.1.14 | 0.441 | |
4a4x | JUP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.441 | |
4fa3 | 0SL | Aldo-keto reductase family 1 member C3 | / | 0.441 | |
4i5x | FLF | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.441 | |
4jq1 | NPS | Aldo-keto reductase family 1 member C2 | / | 0.441 | |
1odc | A8B | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
2hzq | STR | Apolipoprotein D | / | 0.440 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2xuk | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.440 | |
3v94 | WYQ | Phosphodiesterase | / | 0.440 | |
3zj7 | C1K | Strictosidine-O-beta-D-glucosidase | 3.2.1.105 | 0.440 | |
4lsa | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.440 | |
4n65 | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.440 | |
5cc9 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.440 |